French GPs React to COVID-19: Results from AplusA Poll Wave 3

COVID-19

The latest results from our ongoing poll among French GPs monitoring their experiences and...

French GPs React to COVID-19: Results from AplusA Poll Waves 1 and 2

General practitioners are an essential line of defense within the healthcare system in the fight...

COVID-19 INFO #3: Data Collection and More

COVID-19

As the COVID-19 situation develops and as AplusA teams have been receiving questions regarding...

COVID-19 INFO #2: HCP Respondent Response

COVID-19

As the COVID-19 situation develops we want to keep our clients and community updated on the...

Coronavirus: The Evolution of its Many Names

COVID-19

AplusA utilized social media analysis tools to observe the evolution of the use of the different...

COVID-19 INFO #1: Data Collection

COVID-19

AplusA teams have been receiving questions regarding the impact of COVID-19 on market research...

COVID-19 Message of Thanks to AplusA Healthcare Professional Study Participants

Doctor Christine Maï, AplusA Executive Vice-President, sent the following message to the...

AplusA COVID-19 Business Continuity Plan

In light of the current global COVID-19 outbreak, we wanted to share key points from AplusA's...

DLBCL Case Study: Enhancing Patient Journey Research with Social Media Listening

Products and Services, Healthcare Industry, Market Research Industry, Digital

Using the example of a recent AplusA study in Diffuse Large B-Cell Lymphoma (DLBCL), we consider...

Patient Insights from AplusA’s Multiple Myeloma Tracker

hemato-oncology

A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the...